XML 142 R112.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based and Other Incentive Compensation - Stock Appreciation Rights Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash-settled awards    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Outstanding, beginning balance (in shares) 3,452,120  
CSARs converted to SSARs / SSARs converted from CSARs (in shares) (1,978,761)  
Exercised (in shares) (891,866)  
Cancelled (in shares) (470,992)  
Forfeited (in shares) (19,815)  
Outstanding, ending balance (in shares) 90,686 3,452,120
Weighted Average Exercise Price    
Shares outstanding, Weighted average grant price, beginning balance (in dollars per share)   $ 18.77
CSARs converted to SSARs / SSARs converted from CSARs (in dollars per share) $ 21.12  
Exercised (in dollars per share) 7.69  
Cancelled (in dollars per share) 30.06  
Forfeited (in dollars per share) 29.10  
Shares outstanding, Weighted average grant price, ending balance (in dollars per share) $ 15.65  
Shares outstanding, Weighted average remaining contractual life 1 year 18 days 1 year 8 months 19 days
Shares outstanding, Aggregate intrinsic value $ 3 $ 37
Exercisable (in shares) 76,400  
Exercisable (in dollars per share) $ 13.15  
Exercisable, Weighted average remaining contractual life 8 months 15 days  
Exercisable, Aggregate intrinsic value $ 3  
Stock-settled stock appreciation rights    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Outstanding, beginning balance (in shares) 0  
CSARs converted to SSARs / SSARs converted from CSARs (in shares) 1,978,761  
Exercised (in shares) (328,476)  
Forfeited (in shares) (52,146)  
Outstanding, ending balance (in shares) 1,598,139 0
Weighted Average Exercise Price    
CSARs converted to SSARs / SSARs converted from CSARs (in dollars per share) $ 21.12  
Exercised (in dollars per share) 12.84  
Forfeited (in dollars per share) 29.13  
Shares outstanding, Weighted average grant price, ending balance (in dollars per share) $ 22.55  
Shares outstanding, Weighted average remaining contractual life 1 year 11 months 15 days  
Shares outstanding, Aggregate intrinsic value $ 44  
Exercisable (in shares) 660,165  
Exercisable (in dollars per share) $ 13.26  
Exercisable, Weighted average remaining contractual life 9 months  
Exercisable, Aggregate intrinsic value $ 24